On GLP-1 Meds? Lifting Is Not Optional

The Short Answer

GLP-1 medications work for fat loss. They also strip lean mass unless you actively fight it. A 2026 meta-analysis of 20 trials with 15,782 participants shows resistance training reduces the proportion of lean mass lost from 35.2% down to 17.5%. Lifting while on these drugs is not a bonus. It is a requirement.

The Lean Mass Problem Is Real but Not Unique to GLP-1s

The STEP 1 trial, the landmark study that put semaglutide on the map, enrolled 1,961 adults and ran for 68 weeks. Participants lost approximately 15% of their body weight. But approximately 39% of that weight was lean body mass.

One caveat on that figure: STEP 1 enrolled adults with obesity (BMI 30+), not trained lifters. And lean body mass includes water and organ tissue, not just muscle. So the 39% is not 39% muscle loss. It is a broader measure in a clinical population.

That number sounds alarming until you zoom out. A 2026 meta-analysis by Eisa and Barood in Diabetes, Obesity & Metabolism pooled 20 randomized controlled trials with 15,782 total participants. They found that lean mass loss as a proportion of total weight lost was 35.2% for semaglutide, 25.4% for tirzepatide, and 26.8% for liraglutide.

The critical comparison: standard lifestyle interventions without drugs showed 26.2% lean mass loss. The difference between semaglutide and dieting alone was not statistically significant (p=0.42).

In other words, losing a chunk of lean mass is the cost of losing a lot of weight, regardless of method. GLP-1 drugs are not uniquely destructive. But they do make the problem worse if you are not actively protecting muscle.

Resistance Training Cuts Lean Mass Loss Nearly in Half

The same Eisa and Barood meta-analysis broke out a critical subgroup: participants who combined lifestyle changes with resistance training lost only 17.5% of their weight as lean mass. That is half the rate seen with semaglutide alone.

A narrative review in Diabetes Care by Locatelli and colleagues put specific numbers on the stakes. Incretin therapy causes approximately 10% lean mass loss, roughly 6 kg. That is comparable to a decade or more of aging compressed into one treatment cycle.

The review also quantified the offset: supervised resistance training over 10 or more weeks can produce approximately 3 kg of lean mass gains and approximately 25% increases in strength. That does not fully cancel out the 6 kg loss, but it cuts the damage significantly and preserves functional capacity.

The Protein Problem Nobody Talks About

GLP-1 drugs suppress appetite aggressively. That is the point. But it creates a specific problem for muscle preservation: when you do not feel like eating, protein targets become nearly impossible to hit.

The clinical literature recommends at least 1.2 grams of protein per kilogram of body weight per day for people on incretin therapy. For a 90 kg person, that is 108 grams minimum. On a day when the drug has killed your appetite and nausea is lurking, 108 grams feels like a mountain.

Practical strategies that work around GLP-1 side effects:

Time protein around your medication. Most people inject semaglutide weekly. Appetite suppression and nausea peak in the first 2 to 3 days. Front-load higher protein meals on days 4 through 7 when eating feels more normal.

Liquid protein on hard days. When solid food feels impossible, a whey shake with milk gets you 40 to 50 grams without requiring you to chew through chicken breast.

Never skip the post-training meal. Even if it is small. The combination of resistance training plus protein intake is the strongest signal you can send your body to preserve muscle during weight loss.

The Minimum Effective Training Program

You do not need a bodybuilding split. You need the minimum dose that protects lean mass.

Two to three sessions per week. Full body or upper/lower split. Compound movements first: squat variations, hip hinges, presses, rows. 2 to 3 sets per movement to start. The Diabetes Care review data suggests this volume is enough to produce the approximately 3 kg lean mass gain and approximately 25% strength increase that offsets incretin-induced losses.

If you were already lifting before starting GLP-1 medication, do not increase volume. Your recovery capacity is reduced because you are in a significant caloric deficit, even if you did not choose it. Maintain your current program. If anything, reduce volume slightly and focus on keeping loads stable.

One important caveat. No large randomized trial has directly tested a structured resistance training program specifically in GLP-1 users with muscle outcomes as the primary endpoint. The recommendations here are based on the best available indirect evidence. Work with your prescribing physician and adjust based on how your body responds.

Red Flags That You Are Losing Too Much Lean Mass

Watch for these during GLP-1 treatment:

• Strength dropping on lifts where technique has not changed
• Visible loss of muscle fullness despite adequate hydration
• Grip strength declining (easy to test, sensitive to lean mass changes)
• Fatigue during sessions that previously felt moderate

If multiple red flags appear, talk to your doctor about adjusting the dose. Faster weight loss is not better weight loss if it is taking your muscle with it.

About Be Fit and Strong Evidence-based fitness coaching for busy professionals in Dubai. Built by Mirza.

Need a training program designed specifically around your GLP-1 treatment? See how online coaching works at befitandstrong.com.